1. Manicardi M, Milic J, Esposito G, Menozzi M, et al.
   LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis.
   AIDS 2026.
   


2. Song A, Wang H, Fan R, Liu J, et al.
   Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China.
   AIDS Res Hum Retroviruses 2026.
   


3. Chivite I, Merino-Penas MJ, Gonzalez-Cordon A, Martinez-Rebollar M, et al.
   Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.
   Clin Infect Dis 2026.
   


4. Hwang J, Halsey ES, Plucinski MM, Barratt JLN, et al.
   Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data.
   Clin Infect Dis 2026.
   


5. Prior D, Krishnamurti L.
   HIV Status Exclusion in Sickle Cell Gene Therapy.
   JAMA 2026.
   


6. Panichsillapakit T, Broshkevitch CJ, Enders K, Greifinger A, et al.
   Breaking the Chain: HIV-1 Transmission Clusters among People who Inject Drugs in North Carolina, 2010 to 2023.
   J Acquir Immune Defic Syndr 2026.
   


7. Riche RB, Haba N, Bell T, Joseph V, et al.
   "Young Mothers Clubs": Prevention of Mother-to-Child HIV Transmission Among Pregnant Adolescent Girls and Young Women in Haiti.
   J Acquir Immune Defic Syndr 2026.
   


8. Abdalla S, Lallemant M, Compagnucci A, Nardone A, et al.
   Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.
   J Acquir Immune Defic Syndr 2026.
   


9. Barbara Z, Silvia M, Matteo R, Cesanelli F, et al.
   Beyond Body Mass Index: Redefining Obesity Prevalence in an Italian Cohort of People Living With HIV According to the New Lancet Commission's Excess Adiposity Criteria.
   J Acquir Immune Defic Syndr 2026.
   


10. Kulik GL, Wilson MP, Mollner DC, Iriarte E, et al.
    Association of Exercise with Body Image Among Older Adults with and without HIV.
    J Acquir Immune Defic Syndr 2026.
    


11. Espinosa da Silva C, Fatchm R, Emenyonu N, Scheffler A, et al.
    Association of under-reporting of alcohol use with HIV viral non-suppression and an all-cause mortality risk score among people with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr 2026.
    


12. Rensburg RV, Maposa I, Pennefather C, Schreuder C, et al.
    Cumulative Low-Level Viraemia Is Not Associated with Endothelial Function in Black African Adults With HIV.
    J Acquir Immune Defic Syndr 2026.
    


13. Durand C, Hussain S, Kopf S, Mehta S, et al.
    Use of Long-acting Injectable Antiretroviral Therapy in Kidney and Liver Transplant Recipients with HIV.
    J Acquir Immune Defic Syndr 2026.
    


14. Alpert ER, Kent-Marvick J, Caceres O, Perner A, et al.
    A Meta-synthesis on Perceptions of Possibility for HIV Infection Among Cisgender and Heterosexual Women.
    J Acquir Immune Defic Syndr 2026.
    


15. Choga OT, Matsena-Zingoni Z, Choga WT, Lemogang GM, et al.
    Low-Level Viremia and Spatial Heterogeneity Among Individuals on Dolutegravir-Based Antiretroviral Therapy in Botswana: A Nationwide Study (2016-2022).
    J Infect Dis 2026.
    

Display articles in

• Abstract format